Company / EPS (Diluted)
ABEONA THERAPEUTICS INC. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.55
FY2025
5-year range
-$5.53 / -$0.91
FY2021-FY2025
Trend
+38.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 9 years, ranging from $-5.53 in FY2023 to $-0.53 in FY2016.
Based on SEC 10-K filings.
-1.55 in FY2025.
Improved from $-5.53 to $-1.55 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 38.7% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.55 | +38.7% |
| FY2024 | -$2.53 | +54.2% |
| FY2023 | -$5.53 | - |
| FY2022 | - | - |
| FY2021 | -$0.91 | +39.7% |
| FY2020 | -$1.51 | -128.8% |
| FY2019 | -$0.66 | -3.1% |
| FY2018 | -$0.64 | +0.0% |
| FY2017 | -$0.64 | -20.8% |
| FY2016 | -$0.53 | +96.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026